Aldurazyme Injection, Solution, Concentrate
Product Images NDC 58468-0070

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Aldurazyme (NDC 58468-0070). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genzyme Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Aldurazyme 1)

ALDURAZYME 2.9 mg/5 mL (0.58 mg/mL) injection, solution concentrate for intravenous infusion. The packaging label shows a single-dose vial with instructions to dilute prior to use, store refrigerated, and discard unused portion. Manufactured by BioMarin Pharmaceutical and distributed by Genzyme Corporation. Contains no preservatives. The label includes the NDC 58468-0070-1 and Sanofi Genzyme logo.*

FDA Label Image

Vial Label (Aldurazyme 2)

ALDURAZYME 2.9 mg/5 mL injection solution concentrate label for intravenous infusion by Genzyme Corporation. Includes NDC 58468-0070-1, manufacturer BioMarin Pharmaceutical Inc., storage instructions at 2-8°C, and dilution requirement before use. Single-dose vial with lot and expiration date fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.